In a postmenopausal patient with vaginal bleeding, cytological study of the cervical epithelium on Papanicolau is an important diagnostic event. Ultrasound examination can help detect any abnormalities in the data smear. The doctor may perform a CT or MRI scan to visualize organs and determine the stage of disease. The diagnosis of cancer endometrial is made based on symptoms, as well as the general condition of the body.
The prognosis for endometrial cancer depends on the stage and the grade of the tumor. Younger patients are generally more favorable than older ones. The tumor’s histopathological gradation is also a prognostic factor. Low-grade tumors are generally associated with the worst prognosis. Another important prognostic factor is the depth of invasion into the myometrium. Deep invasion into the myometrium significantly affects a patient’s prognosis.
Cancer in the uterus starts to spread through the lymphatic system. The malignant cells are carried along with blood flow to distant organs and tissues. In most cases, hematogenous metastases occur in the lungs, ovaries, and bone tissues, but can also spread to the brain and bone musculature. Consequently, patients with cervical cancer often experience multiple symptoms, including bowel obstruction.
Surgical treatment is a common treatment option for uterine cancer, especially in the early stages. However, there are certain contraindications to surgery, and up to 13% of patients are affixed to severe concomitant pathology. Although surgical treatment is generally the main treatment, a young woman with atypical aplasia may be treated with an endometrium ablation. This treatment option is not for everyone, and many women may need additional surgery.
Other provoking factors that contribute to a uterine tumor include hormonal imbalance and genetic factors. While these factors may increase a woman’s risk of developing cancer, they are not directly responsible for atypical cells. While these factors may increase the risk of developing a disease, the exact mechanism by which an estrogen-dependent tumor develops is largely unknown. Cancer risk is determined by an individual’s unique biology, age, and genetic background.
The growth of endometrial tumors can be associated with an increase in estrogen levels in the body. This increase in estrogen is caused by a hormonal imbalance in the body. This hormone also affects other parts of the body, including the reproductive organs. A woman’s life expectancy is impacted by the growth of tumors and the development of endocrine pathology syndromes. A patient’s survival rate can range from fifty to sixty percent in these cases.
Cancer in the uterus develops in endometrials and may spread to other organs and systems. While women in this age group are most likely to develop this type of cancer, new cases have been reported in women as young as 30. Understanding these early symptoms can lead to timely and effective treatment. For example, cancer of the endometrium can be detected and treated. This way, women can protect their health and prevent this deadly disease from taking its toll on their life.
